Understanding the events and clinical aspects of a patient’s disease journey is fundamental to identifying key inflection points where new therapies and long-standing treatments can be applied to positively impact patient outcomes. This sample dataset provides a detailed view into the patient journey of Psoriasis patients in the United States. It is compiled from an extensive set of US healthcare claims data, and provides visibility into the drugs, diagnoses (comorbidities), and procedures of these patients, as well as the type of Health Care Providers the patients see. In addition, patient counts by US MSA (Metropolitan Statistical Area) are provided along with gender, age, and insurance distributions to support the depth of information supported by the underlying claims dataset.
Data Background:
• Source: US Claims Data, covering 280M patients
• Time Period: Patient Claims analyzed from 2015 to 2020
• Patient Definition: ICD-10 L40 Psoriasis
• Total Patient Count: 1,027,033
Included Data Tables:
• Top 100 drugs prescribed to Psoriasis patients
• Top 50 Diagnoses for Psoriasis patients
• Top 50 Procedures for Psoriasis patients
• Top 25 HCP Specialties treating Psoriasis patients
Patient Counts and Distributions:
o Patient claim counts by US MSA
o Patient prevalence per 100K per US MSA
o Gender Distribution of Psoriasis patients
o Age distribution of Psoriasis patients
o Insurance distribution of Psoriasis patients
About Eversana
EVERSANA™ is the leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.
Usage Information
By subscribing to this product, you agree that your use of this product is subject to the provider's offer terms including pricing information and Data Subscription Agreement .
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing uses a single pricing dimension. Product Access (Units) grants subscribers entry to the product at no charge under the Free model. There are no tiers, instance sizes, or usage add-ons to compare. You get access through this one dimension, which serves as a sample of the patient journey analytics for psoriasis. Pricing does not scale with usage or quantity, so there is nothing extra to configure or meter.
Top-of-mind questions for buyers
What does the Product Access (Units) dimension actually grant me?
It grants entry to this sample of the psoriasis patient journey analytics. Access is provided at no charge under the Free model. One unit maps to product access for the subscriber, so there is no per-user, per-record, or per-dataset metering to track.
Does my cost change as I add users or process more patient data?
No. Pricing does not scale with usage, user count, or data volume. Because this is offered under the Free model with a single access dimension, nothing meters and no threshold triggers extra charges. Your cost stays the same regardless of how much you use.
Is this a full analytics platform or a sample of the patient journey data?
This listing is a sample of the psoriasis patient journey analytics. It shows how the vendor's integrated patient analytics work across the disease journey, such as forecasting, treatment pathways, and trend prediction. Contact the vendor to discuss access beyond this sample.
www.eversana.com
Helpful?
Vendor refund policy
No refunds
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Accelerate your launch of the EVERSANA ORCHESTRATE™ Engine with Modus Create’s Implementation Accelerator—designed specifically for life sciences organizations seeking to scale omnichannel engagement. This 8 to 12-week engagement enables your team to quickly integrate the ORCHESTRATE platform within your AWS environment, leveraging pre-built connectors, FHIR-compliant pipelines, and secure, compliant infrastructure. Whether you’re standing up a pilot or scaling for enterprise use, this accelerator ensures a smooth path to value—built on deep domain expertise and AWS-native tools.